281 related articles for article (PubMed ID: 21455494)
21. Characterization of TRIM5alpha trimerization and its contribution to human immunodeficiency virus capsid binding.
Javanbakht H; Yuan W; Yeung DF; Song B; Diaz-Griffero F; Li Y; Li X; Stremlau M; Sodroski J
Virology; 2006 Sep; 353(1):234-46. PubMed ID: 16808955
[TBL] [Abstract][Full Text] [Related]
22. Structural studies of postentry restriction factors reveal antiparallel dimers that enable avid binding to the HIV-1 capsid lattice.
Goldstone DC; Walker PA; Calder LJ; Coombs PJ; Kirkpatrick J; Ball NJ; Hilditch L; Yap MW; Rosenthal PB; Stoye JP; Taylor IA
Proc Natl Acad Sci U S A; 2014 Jul; 111(26):9609-14. PubMed ID: 24979782
[TBL] [Abstract][Full Text] [Related]
23. Unique features of TRIM5alpha among closely related human TRIM family members.
Li X; Gold B; O'hUigin C; Diaz-Griffero F; Song B; Si Z; Li Y; Yuan W; Stremlau M; Mische C; Javanbakht H; Scally M; Winkler C; Dean M; Sodroski J
Virology; 2007 Apr; 360(2):419-33. PubMed ID: 17156811
[TBL] [Abstract][Full Text] [Related]
24. Fates of retroviral core components during unrestricted and TRIM5-restricted infection.
Kutluay SB; Perez-Caballero D; Bieniasz PD
PLoS Pathog; 2013 Mar; 9(3):e1003214. PubMed ID: 23505372
[TBL] [Abstract][Full Text] [Related]
25. Proteasomal degradation of TRIM5alpha during retrovirus restriction.
Rold CJ; Aiken C
PLoS Pathog; 2008 May; 4(5):e1000074. PubMed ID: 18497858
[TBL] [Abstract][Full Text] [Related]
26. Determinants of the higher order association of the restriction factor TRIM5alpha and other tripartite motif (TRIM) proteins.
Li X; Yeung DF; Fiegen AM; Sodroski J
J Biol Chem; 2011 Aug; 286(32):27959-70. PubMed ID: 21680743
[TBL] [Abstract][Full Text] [Related]
27. Trim5alpha accelerates degradation of cytosolic capsid associated with productive HIV-1 entry.
Chatterji U; Bobardt MD; Gaskill P; Sheeter D; Fox H; Gallay PA
J Biol Chem; 2006 Dec; 281(48):37025-33. PubMed ID: 17028189
[TBL] [Abstract][Full Text] [Related]
28. TRIM5α SPRY/coiled-coil interactions optimize avid retroviral capsid recognition.
Roganowicz MD; Komurlu S; Mukherjee S; Plewka J; Alam SL; Skorupka KA; Wan Y; Dawidowski D; Cafiso DS; Ganser-Pornillos BK; Campbell EM; Pornillos O
PLoS Pathog; 2017 Oct; 13(10):e1006686. PubMed ID: 29040325
[TBL] [Abstract][Full Text] [Related]
29. Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein.
Ohkura S; Goldstone DC; Yap MW; Holden-Dye K; Taylor IA; Stoye JP
PLoS Pathog; 2011 Mar; 7(3):e1002011. PubMed ID: 21483490
[TBL] [Abstract][Full Text] [Related]
30. Binding of the rhesus TRIM5α PRYSPRY domain to capsid is necessary but not sufficient for HIV-1 restriction.
Yang Y; Brandariz-Nuñez A; Fricke T; Ivanov DN; Sarnak Z; Diaz-Griffero F
Virology; 2014 Jan; 448():217-28. PubMed ID: 24314652
[TBL] [Abstract][Full Text] [Related]
31. Contribution of E3-ubiquitin ligase activity to HIV-1 restriction by TRIM5alpha(rh): structure of the RING domain of TRIM5alpha.
Lienlaf M; Hayashi F; Di Nunzio F; Tochio N; Kigawa T; Yokoyama S; Diaz-Griffero F
J Virol; 2011 Sep; 85(17):8725-37. PubMed ID: 21734049
[TBL] [Abstract][Full Text] [Related]
32. Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5α-mediated restriction.
Kono K; Song H; Yokoyama M; Sato H; Shioda T; Nakayama EE
Retrovirology; 2010 Sep; 7():72. PubMed ID: 20825647
[TBL] [Abstract][Full Text] [Related]
33. Adaptation of HIV-1 to cells expressing rhesus monkey TRIM5α.
Pacheco B; Finzi A; Stremlau M; Sodroski J
Virology; 2010 Dec; 408(2):204-12. PubMed ID: 20956011
[TBL] [Abstract][Full Text] [Related]
34. Structure of the rhesus monkey TRIM5α PRYSPRY domain, the HIV capsid recognition module.
Biris N; Yang Y; Taylor AB; Tomashevski A; Guo M; Hart PJ; Diaz-Griffero F; Ivanov DN
Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13278-83. PubMed ID: 22847415
[TBL] [Abstract][Full Text] [Related]
35. Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.
Langelier CR; Sandrin V; Eckert DM; Christensen DE; Chandrasekaran V; Alam SL; Aiken C; Olsen JC; Kar AK; Sodroski JG; Sundquist WI
J Virol; 2008 Dec; 82(23):11682-94. PubMed ID: 18799573
[TBL] [Abstract][Full Text] [Related]
36. Assisted evolution enables HIV-1 to overcome a high TRIM5α-imposed genetic barrier to rhesus macaque tropism.
Soll SJ; Wilson SJ; Kutluay SB; Hatziioannou T; Bieniasz PD
PLoS Pathog; 2013; 9(9):e1003667. PubMed ID: 24086139
[TBL] [Abstract][Full Text] [Related]
37. Defects in assembly explain reduced antiviral activity of the G249D polymorphism in human TRIM5α.
Kömürlü S; Bradley M; Smolin N; Imam S; Pauszek RF; Robia SL; Millar D; Nakayama EE; Shioda T; Campbell EM
PLoS One; 2019; 14(3):e0212888. PubMed ID: 30889178
[TBL] [Abstract][Full Text] [Related]
38. Retroviral restriction factor TRIM5alpha is a trimer.
Mische CC; Javanbakht H; Song B; Diaz-Griffero F; Stremlau M; Strack B; Si Z; Sodroski J
J Virol; 2005 Nov; 79(22):14446-50. PubMed ID: 16254380
[TBL] [Abstract][Full Text] [Related]
39. Rhesus monkey TRIM5α protein SPRY domain contributes to AP-1 activation.
Na L; Tang YD; Wang C; Liu C; Wang X
J Biol Chem; 2018 Feb; 293(8):2661-2674. PubMed ID: 29196608
[TBL] [Abstract][Full Text] [Related]
40. Recent insights into the mechanism and consequences of TRIM5α retroviral restriction.
Sastri J; Campbell EM
AIDS Res Hum Retroviruses; 2011 Mar; 27(3):231-8. PubMed ID: 21247355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
